/
Pharmaceutical preparations company · FY ends Jun · Revenue $169K · -1493.95% margin · -$2M FCF
The business is unprofitable at the operating level (-9526.11% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 65.0% YoY. Margins deteriorated 6533.2pp alongside, both lines moving the wrong way.
ROIC dropped from -87.04% to -1108.75%, capital efficiency is deteriorating. Negative free cash flow of -$4M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$169K
▼ -65.0% YoY
Net Income (TTM)
-$5M
▲ +37.2% YoY
Op. Margin
-1493.95%
▼ -6533.2pp YoY
ROIC
-9.69%
▼ -1021.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$2M
▲ +4.1% YoY
Op. Cash Flow (TTM)
-$2M
▼ -4.3% YoY
Net Debt
$28M
Cash & Equiv.
$8K
3Y CAGR: +7.7%
Continue Research